---
title: "Omnicell, Inc. (OMCL.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/OMCL.US.md"
symbol: "OMCL.US"
name: "Omnicell, Inc."
industry: "Health Care Equipment"
datetime: "2026-05-20T03:57:17.035Z"
locales:
  - [en](https://longbridge.com/en/quote/OMCL.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/OMCL.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/OMCL.US.md)
---

# Omnicell, Inc. (OMCL.US)

## Company Overview

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medication adherence solutions comprising consumables and medication packaging systems; and technology implementation, customer education and training, program management, and related offerings to professional services. In addition, it offers post-installation support and maintenance via phone and/or web, on-site service, parts, and access to software upgrades; software and hardware products for full traceability of medicines and medical supplies throughout the healthcare system; OmniSphere, a cloud-based platform.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.omnicell.com](https://www.omnicell.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:14.000Z

**Overall: C (0.40)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 59 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 7.86% |  |
| Net Profit YoY | -3.55% |  |
| P/B Ratio | 1.56 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 1965598446.98 |  |
| Revenue | 1225057000.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 1.63% | C |
| Profit Margin | 1.67% | C |
| Gross Margin | 45.30% | B |
| Revenue YoY | 7.86% | C |
| Net Profit YoY | -3.55% | C |
| Total Assets YoY | -6.85% | D |
| Net Assets YoY | -0.04% | D |
| Cash Flow Margin | 762.86% | A |
| OCF YoY | 7.86% | C |
| Turnover | 0.59 | B |
| Gearing Ratio | 37.30% | B |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Omnicell, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "7.86%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "-3.55%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.56",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "1965598446.98",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "1225057000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "1.63%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "1.67%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "45.30%",
          "rating": "B"
        },
        {
          "name": "Revenue YoY",
          "value": "7.86%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-3.55%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "-6.85%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-0.04%",
          "rating": "D"
        },
        {
          "name": "Cash Flow Margin",
          "value": "762.86%",
          "rating": "A"
        },
        {
          "name": "OCF YoY",
          "value": "7.86%",
          "rating": "C"
        },
        {
          "name": "Turnover",
          "value": "0.59",
          "rating": "B"
        },
        {
          "name": "Gearing Ratio",
          "value": "37.30%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 97.53 | 43/183 | 751.51 | 81.64 | 62.57 |
| PB | 1.59 | 44/183 | 1.57 | 1.26 | 1.11 |
| PS (TTM) | 1.63 | 42/183 | 1.61 | 1.32 | 1.22 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-01T04:00:00.000Z

Total Analysts: **8**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 6 | 75% |
| Overweight | 1 | 13% |
| Hold | 1 | 13% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 43.82 |
| Highest Target | 70.00 |
| Lowest Target | 55.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/OMCL.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/OMCL.US/norm.md)
- [Related News](https://longbridge.com/en/quote/OMCL.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/OMCL.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**